 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 490 | 回復: 2 | ||
| 當前只顯示滿足指定條件的回帖，點擊這里查看本話題的所有回帖 | ||
[求助]
求助-湯森路透藥物報告 已有1人參與
|
||
|
求助Arbidol的湯森路透藥物報告，謝謝！ [ Last edited by 審雨堂88 on 2014-2-27 at 09:55 ] |
回復此樓» 猜你喜歡
070700求調劑
已經(jīng)有1人回復
-
如何制備符合技術要求的藥品標準品？
已經(jīng)有0人回復
-
藥理學論文潤色/翻譯怎么收費?
已經(jīng)有56人回復
-
高溫高壓反應求助
已經(jīng)有4人回復
-
對照品在藥品研發(fā)中的不可或缺性
已經(jīng)有0人回復
-
求調劑總分327
已經(jīng)有0人回復
-
藥學B區(qū)求調劑
已經(jīng)有0人回復
-
標準品的分類和用途，你知道多少？
已經(jīng)有0人回復
-
重慶醫(yī)科大學-人工智能醫(yī)學學院
已經(jīng)有0人回復
-
重慶醫(yī)科大學-人工智能醫(yī)學學院
已經(jīng)有0人回復
» 本主題相關價值貼推薦，對您同樣有幫助:
- 湯姆森數(shù)據(jù)庫求助
已經(jīng)有7人回復
- 求助一個湯姆森報告
已經(jīng)有3人回復
- 求助索利那新（solifenacin）和帕立骨化醇（paricalcitol） 的湯森路透報告
已經(jīng)有8人回復
- 湯森路透2014需要重點關注的藥物
已經(jīng)有449人回復
- 湯森路透-藥物化學在研發(fā)角色的轉變（2013年6月7日 ）【已搜索無重復】
已經(jīng)有164人回復
- 求：2013版的抗高血壓藥物市場研究報告~
已經(jīng)有5人回復
- 臨床前研究指南（CFDA和FDA，新的和舊的，共四個）
已經(jīng)有206人回復
- 求助湯森路透藥物研究報告
已經(jīng)有4人回復
- 求助關于藥物對照品的問題
已經(jīng)有18人回復
- 糖尿病藥物市場調查報告 2012
已經(jīng)有135人回復
- 降血脂藥物市場研究報告（2012年版）
已經(jīng)有411人回復
- 【求助】緩釋制劑臨床試驗
已經(jīng)有11人回復
- 【求助】請問醫(yī)藥信息調研報告包括哪些方面的內容？
已經(jīng)有20人回復
- 【求助】有關中藥資源調查報告的問題
已經(jīng)有5人回復
- 【求助】求助一篇調查報告
已經(jīng)有9人回復
- 【求助】##藥物生產(chǎn)工藝技術可行性報告怎么寫
已經(jīng)有5人回復
- 【求助】想學計算機輔助藥物設計
已經(jīng)有28人回復
3樓2014-02-27 10:41:51
【答案】應助回帖
★ ★ ★ ★ ★
感謝參與，應助指數(shù) +1
審雨堂88: 金幣+5, ★有幫助, 謝謝 2014-02-27 16:02:09
感謝參與，應助指數(shù) +1
審雨堂88: 金幣+5, ★有幫助, 謝謝 2014-02-27 16:02:09
|
Accession No: 18965 Main Details Drug Name World Status Pharma Status Arbidol Launched Fully Launched Latest Change Updated On By Latest Change 3 Jun 1994 UN Minor change Company Status Data Originator Country Development Stage Non-industrial source Unspecified Launched Activity Data Therapy Description Code Therapy Status Immunostimulant, other I1Z Launched Antiviral, other J5Z Launched Pharmacology Description Code Immunostimulant IM+ Therapy Code Pharmacology Code I1Z J5Z IM+ IM+ Route of Administration Route of Administration Code Alimentary, po A-PO Indication Indication Status Infection, influenza virus Launched Target Data Target Name LocusLink/Entrez Gene ID Unspecified Unspecified -------------------------------------------------------------------------------- Target Family Group(s) Receptor > Cytokine receptor > Class II Chemical Data Origin of Material Code Description CH-SY Chemical, synthetic CAS Registry Number Rotatable Bonds Molecular Formula 131707-23-8 9 C22H26BrClN2O3S Hydrogen Bond Acceptors Hydrogen Bond Donors AlogP Molecular Weight 6 1 4.50 477.42 Chemical Name 1H-indole-3-carboxylic acid, 6-bromo-4-((dimethylamino)methyl)-5-hydroxy-1-methyl-2-((phenylthio)methyl)-, ethylester, monohydrochloride [CAS] Structure New Chemical Entity Yes Patent Data Country Number Priority Country Priority Date WO 9008135 WO 12 January 1989 Country Data Country Name Country Status Year Launched Licensing Op. Argentina - Yes Australia - Yes Austria - Yes Belgium - Yes Brazil - Yes Canada - Yes Chile - Yes China - Yes Colombia - Yes Denmark - Yes Finland - Yes France - Yes Germany - Yes Greece - Yes Hong Kong - Yes India - Yes Ireland - Yes Israel - Yes Italy - Yes Japan - Yes Luxembourg - Yes Malaysia - Yes Mexico - Yes Netherlands - Yes New Zealand - Yes Norway - Yes Peru - Yes Philippines - Yes Portugal - Yes Russian Federation Launched Yes South Africa - Yes South Korea - Yes Spain - Yes Sweden - Yes Switzerland - Yes Thailand - Yes Turkey - Yes UK - Yes USA - Yes Venezuela - Yes Major Events Event Date Act/Est Event Details 15 Oct 1992 Est New Product in Pharmaprojects 15 Oct 1992 Est Licensing Opportunities Worldwide Ratings Novelty Market Size Speed Total Established Strategy (2) US$ 0-500 million (1) Not available (0) Not available Detailed Information Arbidol is an interferon-inducer, developed by Dr I S Nikolaeva of the Centre for Chemistry of Drugs, VNIKhFI, Zubovskay Street 7, Moscow 119517, Russia, as a therapeutic and prophylactic for influenza A and B and other respiratory viral infections (Personal communication, Sep 1992). Marketing It is launched in Russia for therapeutic use in influenza A and B. Clinical Phase III In 2000 influenza patients, Arbidol 0.2g po tid or qid for 3 days reduced the duration of fever, catarrhal syndrome and overall disease, and prevented the development of post-influenzal complications. A prophylactic effect was achieved by 100mg twice/wk. It had an efficacy index of 5.16 (cf 1.0 for ramantadine) (18th Int Cong Chemother (Stockholm), 1993, Abs 190; Personal communication, Jun 1993). In 12 volunteers, 300mg/kg po produced interferon titres of 160IU/ml 24hr after administration (4th BICON (Prague), 1992, Abs 155). Preclinical In cell culture, it inhibited the plaque-forming activity of influenza virus without affecting its haemagglutinating activity. Licensing Arbidol is available for licensing worldwide (Personal communication, Sep 1992). |
2樓2014-02-27 10:17:11
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 329求調劑，一志愿西北工業(yè)大學，材料工程（085601） +5 | 小小機靈蟲 2026-03-29 | 11/550 |
|
|---|---|---|---|---|
|
[考研] 化學308分調劑 +7 | 你好明天你好 2026-03-30 | 8/400 |
|
|
|
[考研] 生物技術與工程 +7 | 1294608413 2026-03-25 | 8/400 |
|
|
|
[考研] 求化學調劑 +11 | wulanna 2026-03-28 | 11/550 |
|
|
|
[考研] 求調劑 +10 | 張zz111 2026-03-27 | 11/550 |
|
|
|
[考研] 一志愿哈爾濱工業(yè)大學材料與化工方向336分 +11 | 辰沐5211314 2026-03-26 | 11/550 |
|
|
|
[考研] 294分080500材料科學與工程求調劑 +8 | 柳溪邊 2026-03-26 | 8/400 |
|
|
|
[考研] 調劑310 +12 | 溫柔的晚安 2026-03-25 | 13/650 |
|
|
|
[考研] 2026年華南師范大學歡迎化學，化工，生物，生醫(yī)工等專業(yè)優(yōu)秀學子加入！ +3 | llss0711 2026-03-28 | 6/300 |
|
|
|
[考研] 295材料工程專碩求調劑 +7 | 1428151015 2026-03-27 | 7/350 |
|
|
|
[考研] 283求調劑 +3 | A child 2026-03-28 | 3/150 |
|
|
|
[考研] 070300求調劑306分 +4 | 26要上岸 2026-03-27 | 4/200 |
|
|
|
[考研] 266求調劑 +11 | 陽陽哇塞 2026-03-27 | 12/600 |
|
|
|
[考博] 26申博 +3 | 加油沖�。� 2026-03-26 | 3/150 |
|
|
|
[考研] 274求調劑 +17 | 顧九笙要謙虛 2026-03-24 | 23/1150 |
|
|
|
[考研] 08開頭275求調劑 +4 | 拉誰不重要 2026-03-26 | 4/200 |
|
|
|
[考研] 348求調劑 +4 | 小懶蟲不懶了 2026-03-27 | 5/250 |
|
|
|
[考研] 總分322求生物學/生化與分子/生物信息學相關調劑 +5 | 星沉uu 2026-03-26 | 6/300 |
|
|
|
[考研] 296求調劑 +4 | 汪��？！ 2026-03-25 | 7/350 |
|
|
|
[考研] 302求調劑 +4 | 錦衣衛(wèi)藤椒 2026-03-25 | 4/200 |
|